OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test
OpGen, Inc. (OPGN)
Last opgen, inc. earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.opgen.com
Company Research
Source: GlobeNewswire
GAITHERSBURG, Md., June 19, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announced today that it has entered into a global supply agreement to use Thermo Fisher Scientific’s technology to support the commercialization of its rapid molecular products and informatics system to help combat multidrug-resistant infections. OpGen will combine Thermo Fisher’s real-time PCR solutions with its genomic analysis and bioinformatics technology to help healthcare providers rapidly and accurately identify bacterial antibiotic susceptibility using resistance gene profiles. Under the terms of the agreement, OpGen will commercialize the Acuitas Rapid Test for Pathogen ID and resistance genes on Thermo Fisher’s new mid-throughput real-time PCR system. The effort will be supported by local labs that will be able to interpret results using customized analysis software and OpGen’s cloud-based Acuitas Lighthouse® Knowledgebase to match genomic analysis data with antibiotic susceptibility informatio
Show less
Read more
Impact Snapshot
Event Time:
OPGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPGN alerts
High impacting OpGen, Inc. news events
Weekly update
A roundup of the hottest topics
OPGN
News
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen Announces Acquisition of Preferred Stock by David Lazar [Yahoo! Finance]Yahoo! Finance
- OpGen Announces Acquisition of Preferred Stock by David LazarGlobeNewswire
OPGN
Earnings
- 11/14/23 - Miss
OPGN
Sec Filings
- 4/17/24 - Form 8-K
- 4/16/24 - Form PRE
- 4/15/24 - Form 4
- OPGN's page on the SEC website